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Antimycinc1 complex catalyzes the oxidation–reduction of quinol and quinone at sites
located in opposite sides of the membrane in which it resides. We review the kinetics of electron transfer and
inhibitor binding that reveal functional interactions between the quinol oxidation site at center P and
quinone reduction site at center N in opposite monomers in conjunction with electron equilibration between
the cytochrome b subunits of the dimer. A model for the mechanism of the bc1 complex has emerged from
these studies in which binding of ligands that mimic semiquinone at center N regulates half-of-the-sites
reactivity at center P and binding of ligands that mimic catalytically competent binding of ubiquinol at center
P regulates half-of-the-sites reactivity at center N. An additional feature of this model is that inhibition of
quinol oxidation at the quinone reduction site is avoided by allowing catalysis in only one monomer at a
time, which maximizes the number of redox acceptor centers available in cytochrome b for electrons coming
from quinol oxidation reactions at center P and minimizes the leakage of electrons that would result in the
generation of damaging oxygen radicals.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe cytochrome bc1 complex is present in the inner membrane of
most mitochondria and heterotrophic bacteria. The functional core of
this respiratory enzyme is comprised of the highly hydrophobic
diheme cytochrome b associated with the trans-membrane regions of
the Rieske iron–sulfur protein and cytochrome c1. One of the most
surprising features revealed by the atomic-resolution structures of the
bc1 complex [1–5] is that this enzyme can only function as a dimer
(Fig. 1). The inclination of the trans-membrane helix of the Rieske
protein results in the interaction of its extramembrane domain with
the quinol oxidation site (center P) of cytochrome b in the opposite
monomer.
In the protonmotive Q cycle mechanism [[6], reviewed in Ref. [7]],
one of the two electrons coming from the oxidation of quinol at center
P, located close to the positive side of the membrane, is transferred to
cytochrome c via the Rieske protein and cytochrome c1. The other
electron from quinol moves from the bL to the bH heme across the
membrane dielectric and reduces quinone bound at center N to form a
stable, tightly bound semiquinone [8–10]. A further quinol oxidation
event at center P donates the electron needed to reduce semiquinone
to quinol at center N. The deprotonation of quinol at center P and the
protonation of quinone at center N results in the net movement of
protons across the membrane, which together with the movement of1 603 650 1128.
umpower).
l rights reserved.the negative charge of the electron from bL to bH, contributes to the
formation of a protonmotive gradient.
Having two sites catalyzing the same net reaction in opposite
directions (oxido-reduction of quinol/quinone) introduces the poten-
tial for signiﬁcant inhibition of quinol oxidation at center P by the
reversibility of reactions at center N. The lack of oxidized acceptors in
cytochrome b for the second electron coming from center P would
result in detrimental reactions, such as the one-electron reduction of
oxygen to form superoxide [11]. Therefore, mechanisms that avoid the
accumulation of electrons in cytochrome b are expected to exist in the
bc1 complex. In this article, we review the experimental evidence
showing how the dimeric structure of the bc1 complex allows the
regulation of center P and center N in a manner that maximizes the
availability of electron acceptors in cytochrome b in order to avoid
electron leakage out of center P.
2. Half-of-the-sites activity at center P
2.1. Inactivation of one center P in the presence of antimycin
One possible mechanism that can be envisioned in order to
decrease spurious electron transfer to oxygen in a dimeric bc1
complex is to avoid simultaneous quinol oxidation at both center P
sites. Evidence for the existence of this mechanism was ﬁrst provided
in pre-steady-state assays in which the semi-puriﬁed bovine complex
was reduced with duroquinol, a more hydrophilic analog of ubiquinol
[12]. It was reported that with antimycin bound at both center N sites
only half of the iron–sulfur clusters and of the c1 hemes were reduced
Fig. 1. Structure of the catalytic subunits of the yeast bc1 complex dimer. Cytochrome b
(green), the Rieske iron–sulfur protein (blue), and cytochrome c1 (red) are colored in
one monomer and shown as ribbons. Notice the tilted trans-membrane helix of the
Rieske protein that is imbedded in one monomer and connects through a ﬂexible linker
region to the extrinsic iron–sulfur cluster containing domain that interacts with the
other monomer. Redox centers (c1, bL and bH hemes, and the FeS cluster), as well as the
center P inhibitor stigmatellin (Stg) and the center N ubiquinone (Ubi) are shown as
ball-and-stick models. The structure is taken from Protein Data Bank code 1EZV [4].
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much more slowly, possibly by the one-electron oxidation of
duroquinol that accompanies superoxide formation at center P [11].
However, this result was interpreted as indicating that antimycin
could bind directly to one quinol oxidation site in the dimer [12],
which has been disproved by the structural information now available
[13].
It has also been claimed [14] that the incomplete reduction of the
Rieske protein and of cytochrome c1 in the presence of antimycin
(which blocks the oxidation of the bH heme through center N) is
simply a consequence of only one quinol oxidation event occurring in
every center P. Since a second quinol oxidation would imply the
reduction of heme bL (which has a redox potential 120–150 mV lower
than that of bH), this interpretation assumes that the less favorable
equilibrium constant for a second turnover when the bH heme is
already reduced would allow only one electron coming from the ﬁrst
catalysis at each center P to reside in either the Rieske protein or
cytochrome c1.
We have excluded the “one turnover per monomer” explanation
for the missing cytochrome c1 reduction in the presence of antimycin
[14] by using conditions inwhich even a single quinol oxidation event
should result in an electron residing preferentially in cytochrome c1
[15]. This was accomplished with the yeast bc1 complex by using
alkaline conditions to decrease the pH-dependent redox potential of
the Rieske protein, or by mutation of one of the residues that controls
the redox potential of the iron–sulfur cluster. As shown in Fig. 2 where
data from Ref. [15] is reproduced, both at pH 8.8 with the wild-type
yeast enzyme (Fig. 2A), or at neutral pH with the Y185F Rieske mutant
(Fig. 2B), cytochrome c1 reduction (corrected for the contribution of
the bH heme at the measured wavelengths) stays below 50% in the
presence of antimycin (red traces). In both cases, the redox potential of
the Rieske protein is 60–70 mV lower than cytochrome c1, resulting in
an expected reduction of ~80% of the c1 heme, assuming every centerP catalyzed one quinol oxidation reaction. This was approximately the
reduction level attained in the uninhibited enzyme (blue traces in
Fig. 2), indicating that both center P sites in the dimer are able to react
when center N is free to recycle electrons.
Since quinol can reduce the bH heme directly by binding to center
N in a reaction faster than that through center P, cytochrome c1
reduction did not reach 100% in the absence of antimycin due to the
amount of pre-reduced bH present before the ﬁrst turnover at center P.
However, in the presence of the center N inhibitor (red traces in Fig. 2),
the observed reduction level in c1 could be accurately explained by
assuming that one turnover occurred only at half of the center P sites
(solid black line), but not in bothmonomers (dashed line). Simulations
that included the calculated equilibrium constants for quinol oxida-
tion in the presence of antimycin [15] showed that a second turnover
(Keq ~1) was possible under the conditions used, explaining the
further reduction of c1 from 40% to 50% (red traces in Fig. 2). We also
demonstrated that in the presence of several equivalents of oxidized
cytochrome c, which further favor a second turnover at the active
center P, only two turnovers per dimer occur when antimycin is bound
to the enzyme, again indicating that one center P per dimer was
inactive [15]. The well-known phenomenon of oxidant-induced
reduction of at least part of the bL hemes in the presence of antimycin,
shown both in bacterial [16] and mitochondrial enzymes [17],
indicates that further turnovers at the active center P site are possible
even when the bH hemes are reduced, as long as cytochrome c is
present and maintained oxidized, and enough quinol is available.
Under such conditions, a single active center P site per dimer could
reduce any of the two bL hemes provided that there is electron
communication between them. Evidence for inter-monomeric elec-
tron transfer is discussed below (Section 4).
Similar results to those shown in Fig. 2 were obtained with the
Paracoccus denitriﬁcans bc1 complex [18], indicating that this half-of-
the-sites activity is not exclusive to yeast, but is a conserved feature
even in the simpler bc1 complexes from bacteria, which are devoid of
the non-redox subunits present in the eukaryotic complexes. The
bacterial enzyme has mostly been studied in chromatophore
membranes of Rhodobacter [19,20], in which the bc1 complex is
present together with the endogenous ubiquinone pool (which is
usually poised at a particular redox potential with artiﬁcial mediators)
and the diffusible cytochrome c2 (equivalent to the soluble cyto-
chrome c of mitochondria). However, little attention has been given in
these studies as to the reasons that could account for the incomplete
reduction of the c-type cytochromes in the presence of antimycin,
which is ~30% of the extent observed in the uninhibited condition at
neutral pH [14], except for the “one turnover per monomer” argument
discussed above.
Nevertheless, a dimeric alternating mechanism for quinol oxida-
tion at center P has been proposed for the bacterial bc1 complex in
chromatophores [21]. This model proposed that the oxidation of one
quinol molecule per dimer could only be driven by the thermo-
dynamically more favorable catalysis at center P in the other
monomer, and that the presence of either semiquinone or quinol at
center N could determine whether quinol oxidation at each center P
could occur. However, this proposal assumed that absolutely no
ubiquinol could be formed by the bacterial reaction center upon a
single, low intensity ﬂash, and that one ubiquinol molecule per dimer
stayed reduced for several seconds even at an oxidizing redox
potential of 250 mV in the presence of redox mediators (implying
that it remained tightly bound to center P), even though it was readily
oxidized upon activation of the reaction center by the weak ﬂash [21].
In addition, the equilibrium constants for center P turnovers were
assumed to be determined by the redox potential of the semiquinone
or quinone molecules bound at center N, and not by the potential of
the bH heme, which is the actual electron acceptor. The experimental
support for this model was thus questionable at the time it was
proposed, although some of its postulates, such as an alternating site
Fig. 2. Pre-steady-state reduction of cytochrome c1 in the yeast cytochrome bc1 complex. Cytochrome bc1 complex (3 μM) of wild-type yeast at pH 8.8 (A) or of the Y185F Rieske
mutant at pH 7.0 (B) was rapidly mixed with 12 μM of decyl-ubiquinol in the presence (red traces) or absence (blue traces) of 6 μM antimycin. Contribution of cytochrome b
absorbance at the indicated wavelengths was corrected for as described in Ref. [15]. Black curves represent the simulated cytochrome c1 reduction assuming that only one (solid line)
or both (dotted line) center P sites catalyzed only one quinol oxidation reaction. Simulations also assumed ~80% occupancy of the electron in c1 and ~20% in the Rieske protein. Data
and simulations are reproduced from Ref. [15], where the full details of the kinetic modeling are provided.
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two monomers, and the conformational coupling between centers P
and N, have been conﬁrmed by more recent studies, as discussed in
this review.
The complexity of the chromatophore system, where reaction
centers form ternary complexes with an undetermined fraction of the
bc1 complexes in the chromatophore membrane to reduce ubiquinone
and simultaneously oxidize the c-type cytochromes to generate
ubiquinol in the pool, increases the difﬁculty in interpreting kinetic
data in terms of a dimeric mechanism. In contrast, the simpler assays
in which the isolated bc1 complex is mixed with known concentra-
tions of substrates and products have led to more straightforward
conclusions involving the functional relevance of the dimer [15,18].
The solubilized enzyme system also allows working below the Km
values for quinol simply by increasing the detergent concentration.
This results in lower reaction rates that are amenable to the collection
of complete spectra every millisecond. The under-saturation of the
enzyme with respect to its substrate does not change the rate limiting
step, since center P catalysis is still controlled by the midpoint
potential of the Rieske protein [22], as has also been observed in
chromatophores [23]. Moreover, the reliability of the isolated enzyme
system is illustrated, for example, by the linear Arrhenius plots for the
determination of activation energies that are obtained with this
experimental setup [24], but not with the chromatophore system [25].
2.2. Asymmetric binding of inhibitors to center P: evidence of
anti-cooperative quinol oxidation
The inactivation of quinol oxidation at one center P per dimer
when ligand is bound at center N in both monomers suggests that the
interaction of the extrinsic domain of the Rieske protein with the
surface of cytochrome b is altered, preventing the formation of the
enzyme–substrate complex. This productive conﬁguration is thought
to resemble the conformation observed in crystal structures when
stigmatellin is bound to center P [1,4]. This inhibitor forms a hydrogen
bond to one of the histidine residues that ligates the iron–sulfur
center, and this same interaction is thought to exist between quinol
and the Rieske protein in order for electron transfer to occur. Tight
binding of stigmatellin requires the presence of the Rieske protein in
the bc1 complex [26], and its binding site shows signiﬁcant changes
depending on the position of the Rieske extrinsic domain [27].Therefore, if the bc1 complex dimer functions by allowing only one
center P to be active at a time, stigmatellin should bind differently to
each center P in the dimer.
This is precisely what we have found by analyzing the binding of
stigmatellin to the P. denitriﬁcans bc1 complex, which exhibits a
signiﬁcant blue shift of the bL heme absorbance peak upon binding of
this inhibitor [18]. As shown in Fig. 3, stigmatellin binds to one half of
the center P sites more rapidly than to the other, generating in the end
an asymmetric shift on the bL spectrum, which indicates a different
conﬁguration of the inhibitor in half of the sites. Deconvolution of the
spectral shift produced by each kinetic binding phase showed that the
initial faster binding event generated a symmetric shift, while the
slower binding resulted in a change in the shape of the bL spectrum,
indicating a slightly different position of the inhibitor in each center P
[18]. In addition, the rate of the slow phase of stigmatellin binding was
shown to be independent of inhibitor concentration, which suggests a
sequential binding process that requires a slow conformational
change after the initial binding to the ﬁrst half of the center P sites.
The difference in the rate of the two phases increased, while the
extent of the slower phase decreased, at higher stigmatellin con-
centrations [18], indicating that heterogeneity in the enzyme sample
(which also exhibited full cytochrome c1 reduction activity) was not
responsible for the biphasic binding of the inhibitor. We have
interpreted the progressive loss in the extent of the slow phase of
stigmatellin binding to the ability of the inhibitor at higher con-
centrations to bind to the second monomer before a conformational
change induced by binding to the ﬁrst monomer modiﬁes the second
center P site [18]. Therefore, these results support the conclusion that
one center P in the dimer is impeded at least partially from acquiring
the catalytically competent conﬁguration in which the Rieske protein
is able to accept electrons from quinol. This might be achieved not
only by an effect on the position of the extrinsic domain of the Rieske
protein in the secondmonomer, but also by any change that decreases
the afﬁnity toward quinol in the second center P. Either of these
mechanisms, or a combination of both, would result in the observed
anti-cooperative oxidation of quinol.
Additional evidence supporting a half-of-the-sites activity at
center P was obtained by titrating the steady-state activity of quinol
oxidation with inhibitors that are sensitive to the position of the
extrinsic domain of the Rieske protein [28]. It was found that only one
molecule per dimer of stigmatellin or MOA-stilbene was sufﬁcient for
Fig. 3. Asymmetric binding of stigmatellin to the Paracoccus denitriﬁcans cytochrome bc1 complex. The time-dependent course of 15 μM stigmatellin binding to 2 μM reduced bc1
complex (red trace in panel A) is ﬁtted better (solid black curve) using a biphasic exponential function as compared to a monophasic equation (dotted blue curve), as shown by the
corresponding residual plots in the insert. The rate of each binding phase obtained from the biphasic ﬁt is shown in parentheses along with its relative contribution to the total
spectral change. The change in the absorbance spectrum of the bL heme generated by the binding of stigmatellin (panel B) is asymmetric, with a trough amplitude that is twice the
magnitude of the peak. As described previously in Ref. [18], where data is taken from, most of the asymmetry is generated during the slow binding phase.
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center P was active and in the correct conformation to allow efﬁcient
binding of these inhibitors. The rate constant for stigmatellin binding
has been found to be higher when the Rieske protein is reduced, even
though its binding to center P is still tight when the enzyme is fully
oxidized [29]. The binding of MOA-stilbene is also sensitive to the
redox state of the Rieske protein [30], indicating that the position of
the extrinsic domain of the Rieske protein, which inﬂuences the redox
potential of the iron–sulfur cluster [31,32], modiﬁes the afﬁnity for
these two inhibitors.
In contrast, myxothiazol, the binding of which is largely insensitive
to the position of the Rieske protein [30], was apparently able to bind
to both active and inactive center P sites, given that twomolecules per
dimer were needed to completely block the activity [28]. In agreement
with this result, we observed that myxothiazol binds with a single rate
to all center P sites of the P. denitriﬁcans bc1 complex, generating a
symmetrical spectral shift of the bL heme [18]. This homogeneous
binding of myxothiazol obviates the possibility of heterogeneity in
the enzyme preparation. Nevertheless, under some circumstances
even myxothiazol seems to bind preferentially to one monomer, as
observed in a mutant yeast bc1 complex in which the Rieske protein
lacks the iron–sulfur center [33].
3. Interaction between center P and center N sites in the dimer
3.1. Asymmetric binding of antimycin to center N
The above mentioned observation that one quinol oxidation site in
the dimer is inactivated in the presence of antimycin, but not in its
absence (see Fig. 2), implies conformational communication between
center P and center N. A number of observations agree with this
assumption, including the increased mobility of the Rieske extrinsic
domain in the presence of antimycin as measured by its susceptibility
to proteolysis [34], as well as the modiﬁed interaction of the Rieske
protein with center P ligands by center N mutations [35]. In line with
this evidence, we found that the binding kinetics of antimycin tocenter N measured by the red shift generated in the bH spectrum is
affected by center P ligands [36]. As shown in Fig. 4A, where data from
Ref. [36] is reproduced, the binding of antimycin when center P is
occupied by myxothiazol is monophasic, and its rate is concentration-
dependent (Fig. 4C), which indicates that the binding is homogeneous
and limited by the diffusion of the inhibitor into center N. This
experiment obviates the possibility of a heterogeneous mixture of
damaged and intact enzyme. Identical results were obtained in the
absence of center P inhibitors [36].
However, when stigmatellin occupies center P, antimycin binding
to half of the center N sites is slower and concentration-independent
(Fig. 4B, D, taken from Ref. [36]), which indicates that one monomer
cannot bind the inhibitor until binding to the ﬁrst center N site
induces a relatively slow conformational change that enables binding
to the secondmonomer. Since stigmatellin (but not myxothiazol) ﬁxes
the position of the Rieske protein to the proximity of center P [27,37],
our conclusion from these studies is that when both center P sites in
the dimer are in the catalytically competent conformation, only one
center N is able to bind ligands effectively. Perhaps related to this
interpretation, we have found that a mutation that prevents the
insertion of the iron–sulfur cluster into the Rieske cluster also results
in the binding of antimycin to only half of the center N sites [33].
A further relevant result from the antimycin binding studies [36]
was that quinol did not slow the binding of the inhibitor, indicating
that antimycin and quinol bind to different conformations of center N.
This suggests that antimycin, which is a tightly bound ligand (Kdb10−9
M [38]), mimics the stable semiquinone intermediate found at this
site. Although it has long been known that semiquinone formation at
center N is impeded by antimycin [8–10], it has more recently been
proposed that this inhibitor mimics quinol [35]. However, the most
straightforwardway to interpret the insensitivity of antimycin binding
rate with respect to the increase in quinol concentration is that these
two center N ligands do not compete with each other for the same
conformation of center N. Moreover, antimycin binds tightly to center
N irrespective of the redox state of the bH heme, as judged by its
lack of effect on the midpoint potential of the heme [39], just as
Fig. 4. Kinetics of antimycin binding to center N in the presence of center P inhibitors. Antimycin (20 μM) binds in a single phase in the presence of 1.2 equivalents of myxothiazol per
bc1 monomer, present at a concentration of 2.5 μM (panel A) and in two phases in the presence of stigmatellin (panel B). The relative contribution of each kinetic phase in panel B is
shown in parentheses next to its rate. The single rate observed with myxothiazol bound at center P is linearly dependent on the concentration of antimycin (panel C). With
stigmatellin occupying the center P sites (panel D) binding of antimycin is concentration-dependent during the ﬁrst kinetic phase (ﬁlled red circles and solid red line), but is
concentration-independent during the slow second phase (open red circles, dotted red line), indicating that a conformational change limits binding of antimycin to half of the center
N sites when stigmatellin is occupying both center P sites in the dimer. Data reproduced from Ref. [36].
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proposal [40] that antimycin mimics the stable semiquinone inter-
mediate. Therefore, it can be assumed that oxidation of quinol occurs
at only one center P when semiquinone is occupying both center N
sites, as observed when antimycin is bound to both monomers (see
Fig. 2). In turn, the rapid binding of antimycin to only one center N
when both center P sites are ﬁxed by stigmatellin in a conformation
that resembles the active state (Fig. 4B) implies that whenever
semiquinone is stabilized at only one center N site, both center P sites
become catalytically competent for quinol oxidation. Experimental
evidence supporting these assumptions is discussed in more detail
below.
3.2. Half-of-the-sites activity at center N
The physiological relevance of the antimycin binding results was
tested by analyzing the kinetics of cytochrome b reduction through
center N when center P was inhibited by stigmatellin or myxothiazol
[36,41]. Under these conditions, quinol binds to center N, followed by
the formation of a stable semiquinone upon the one-electron reduc-
tion of the bH heme [42,43]. The kinetic traces in Fig. 5, reproduced
from Ref. [41], show that the pattern of bH reduction is sensitive to thetype of center P inhibitor present, conﬁrming the existence of a com-
munication pathway between center P and center N. In the presence
of stigmatellin, the reduction kinetics include a slow reoxidation
phase not observed with myxothiazol. Also, the extent of bH reduction
remained higher with stigmatellin blocking center P than with
myxothiazol. Interestingly, in both conditions quinone was unable to
fully oxidize cytochrome b, and did not affect the initial rate of
reduction by quinol, indicating a lack of competition between the two
substrates of center N [41]. We also showed that, after equilibration,
the EPR properties of semiquinone at center N in the presence of
myxothiazol or stigmatellin were the same as in the uninhibited
enzyme, indicating that the center P inhibitors were not exerting any
signiﬁcant changes in the redox potential of the tightly bound radical
or the bH heme [41]. In agreement with this observation, it has been
shown in different bc1 complexes that stigmatellin and myxothiazol
induce negligible changes in the midpoint potential of the bH heme
[39,44].
We were able to model the fairly complicated kinetic pattern of bH
reduction through center N [41] by assuming the three conditions
illustrated in Fig. 6. First, quinol binds to center N preferentially when
the bH heme is oxidized, and quinone when the heme is reduced
(intermediates I, III and III′). Second, one center N in the dimer is not
Fig. 5. Reduction of heme bH through center N in the presence of center P inhibitors. Reduction of 1.5 μM yeast bc1 complex by decyl-ubiquinol (24 μM) was determined in the
presence of 1.2 equivalents of myxothiazol (panel A) or stigmatellin (panel B) at different decyl-ubiquinone (Q) concentrations. The solid black lines represent the ﬁt of each kinetic
trace to a biphasic or triphasic function. Data reproduced from Ref. [41].
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site has done so (reaction 1 leading to intermediate II). The differences
in the kinetics of bH reduction through center N in the presence ofFig. 6. Model of electron equilibration at center N in the dimeric bc1 complex.
Cytochrome b dimers are shown as paired rectangles with center N sites as circles next
to the bH hemes. All other subunits, as well as center P reactions, have been omitted for
clarity. The model assumes that quinol (QH2) binds only to center N sites with an
oxidized (white) bH heme, and that quinone (Q) binds exclusively when bH is reduced
(black). Semiquinone (SQ) formation is initially prevented in one center N (hatched
circle in intermediate I). Solid arrows indicate changes that result from binding of a
quinone or quinol ligand to a center N site or by electron transfer between heme and a
ligand in one monomer. Yellow arrows, including the curved yellow arrow in
intermediate III′, indicate changes that depend on electron transfer from one bH to
the other via the bL hemes as discussed more fully in the text.different center P inhibitors can be explained by assuming that stig-
matellin bound at the center P sites signiﬁcantly slows down the
activation of the second center N site. Third, electrons are able to
equilibrate between the two center N sites in the dimer. Although the
evidence for this last assumption is more fully explained in the next
section, it is clear from the model in Fig. 6 that quinone would not be
able to decrease the extent of bH reduction (reaction 3′ leading to
intermediate IV′) unless the electron from the ﬁrst center N (where
semiquinone is now tightly bound) is able to reduce the oxidized bH
heme in the other monomer, allowing the binding of quinone
(reaction 2′ leading to intermediate III′). Electron equilibration be-
tween monomers also explains why bH oxidation even at high
quinone concentrations is only partial (see Fig. 5), yielding a mixed
population of intermediates III and III′. Whenever the electron is still
residing in the bH heme of the ﬁrst center N (intermediate III), quinol
will be able to bind to the second center N and reduce its bH heme
(reaction 3 leading to intermediate IV).
The mechanism of half-of-the-sites activity at center N presented
in Fig. 6 allows for the existence of at least a fraction of the bc1
complex dimers with two semiquinones, each one next to an oxidized
bH heme [41,45]. This conﬁguration, with cytochrome b fully oxidized
and insulated from reduction by reverse quinol oxidation at center N,
is optimal for unimpeded center P catalysis, and could not exist at
signiﬁcant concentrations when quinol/quinone ratios are high unless
the three conditions outlined above are met. It is true that the
conditions in which center N functions by itself while center P is
completely blocked are rarely to be found physiologically (see Fig. 5).
However, the fact that quinol oxidation at center P is signiﬁcantly
slower than the reversible reactions at center N indicates that all the
reactions shown in Fig. 6 have enough time to occur between catalytic
turnovers at center P. Therefore, a half-of-the sites mechanism at
center N allows cytochrome b to be poised in the right redox state to
receive the electron from the next quinol oxidation event at center P.
Recently, a dimeric mechanism for the bacterial bc1 complex was
proposed that assumes that only one semiquinone per dimer can be
formed [20], an idea already featured in a much earlier proposal [12].
The alleged basis for this model is the observation that no more than
~0.5 semiquinone equivalents per bc1 monomer are detected by EPR
in redox titrations [8–10,39,41], even after correcting for the
antiferromagnetic silencing of the EPR signal when the bH heme is
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dimeric model [20], the electron in the semiquinone formed in one
monomer must be in equilibrium with the oxidized bH heme in its
vicinity given the midpoint potentials of the heme and of the redox
couples involved in semiquinone formation. When these potentials
are considered, it has been shown by simulations that the 0.5
equivalents of semiquinone observed per dimer are simply the result
of the probability of the electron residing in semiquinone or in the bH
heme at a given time [39]. We have also simulated semiquinone
equilibration at both monomers, suggesting that a mixture of dimers
with zero, one or two semiquinones could account for an average of
b0.5 equivalents per center N site depending on the quinol/quinone
ratio [41]. The only condition in which one center N in the dimer
exhibits a lower ligand occupancy is in the presence of stigmatellin, as
reported for the yeast bc1 complex crystallized with cytochrome c
[47]. In the uninhibited enzyme, other crystal structures have shown
ubiquinone bound at both center N sites [13,48], implying that
semiquinone could potentially be formed in both monomers. The
antimycin binding results we have discussed above (see Section 3.1)
also support the notion that ligands such as semiquinone can be
rapidly stabilized at both center N sites, except for the condition in
which the Rieske protein is ﬁxed close to center P in both monomers
(as occurs in the presence of stigmatellin), where tight binding to one
center N is impaired at least temporarily.
3.3. Possible routes for conformational communication in the dimer
The wealth of structural information available from crystallo-
graphic studies of the bc1 complex [1–5,13,27,47,48] can be examined
in an attempt to identify regions of cytochrome b that might be
involved in transmitting conformational changes from center P and
center N within each monomer and across the dimer. Large-scale
differences in center P or center N when an inhibitor is bound at the
other site are not observed, indicating either subtle or short-lived
conformational changes. Nevertheless, it has been carefully docu-
mented how center P inhibitors signiﬁcantly modify the surface of
cytochrome bwhere the extrinsic domain of the Rieske protein docks
in order to catalyze quinol oxidation [27]. This region of the protein
includes the CD and EF loops and helices, which are connected toFig. 7. Close-up view of a potential conformational communication pathway between center
colored in only onemonomer. Residues proposed to be important for inter-monomeric comm
mediated hydrogen bond to His-202 in the colored monomer. The structure is excerpted frocenter N residues through the D and E trans-membrane helices. In this
regard, a change in rigidity of the D helix has been suggested upon
binding of antimycin, which produces subtle changes in the EPR
spectrum of the bL heme in a bacterial bc1 complex [35]. We have also
reported that reverse quinol oxidation at center N can be perturbed by
some center P mutations [49]. Still, the exact mapping of the
communication pathway between center P and center N within the
same monomer awaits further mutational studies.
Structural asymmetries between monomers are impossible to see
in most crystal structures simply because they have a monomer in the
asymmetric unit [50], resulting in the averaging out of any differences
between monomers. The few structures that have a dimer in the
asymmetric unit have revealed potentially interesting differences
between monomers. In the bovine bc1 complex dimer [3], it has been
revealed that in one monomer the Rieske extrinsic domain is
relatively static in an intermediate position between the interfaces
with cytochrome b and cytochrome c1, while in the other monomer
the Rieske domain is highly movable as indicated by its high degree of
disorder. The yeast bc1 complex crystallized in the presence of
cytochrome c and stigmatellin [47] has shown a signiﬁcantly different
quinone occupancy at the two center N sites while cytochrome c is
bound to only one monomer. We have proposed that center P in one
monomer could be inﬂuenced by center N in the other monomer
through the trans-membrane region of the Rieske protein, which
traverses the dimer, given that some residues from the Rieske trans-
membrane region are in contact with cytochrome b residues of helix E
on the side facing away from center N [33]. However, residues from
the trans-membrane region of cytochrome c1 are wedged between
the Rieske protein and center N in the vertebrate and bacterial
enzymes[1–3], implying a lack of conservation in this region.
It seems more likely that center P and center N communicate
within each monomer, and that the inter-monomeric conformational
changes are transmitted at the level of the center N sites through the
amino-terminal region of each cytochrome b [36]. Fig. 7 illustrates
how the helical region between Tyr-9 and Ile-17 of the yeast
cytochrome b extends parallel to the plane of the membrane to
make contact with Met-196, Met-199 and Ala-200 of the opposite
monomer. These residues are close to His-202, which is one of the key
residues for binding and catalysis at center N [4,51,52]. This helix is inN sites in the yeast bc1 complex dimer. Atoms and the backbone portions of helices are
unication are indicated, along with the bH heme and ubiquinone (Ubi) bound via awater
m the stigmatellin-bound bc1 complex (Protein Data Bank code 1EZV [4]).
Fig. 8. Distances between hemes in the yeast bc1 complex dimer. Edge-to-edge
distances between heme tetra-pyrrole rings are indicated by arrows along with the
heme redox midpoint potentials as measured in the isolated yeast bc1 complex. The
approximate locations of the center P and center N reaction sites are also shown with
the respective inhibitors that block each site: stigmatellin (Stig), myxothiazol (Myxo),
and antimycin (Anti). The structure was excerpted from PDB code 1EZV [4].
Fig. 9. Simulation of electron equilibration between the b hemes of the bc1 complex
dimer. Electron transfer rates between hemes were calculated using the equations in
Refs. [56,59] (solid curves) or in Ref. [60] (dashed curves) to estimate the kinetics of
electron equilibration starting from the condition inwhich an electron resides in one bH
heme. Changes in the relative concentration of dimers with the electron in the initial bH
heme (black curves), in the bL heme of that same monomer (blue curves), in the
opposite bL heme (green curves), or in the opposite bH heme (red curves) are shown.
Details of the simulation program and the script ﬁle can be found in Ref. [45].
1086 R. Covian, B.L. Trumpower / Biochimica et Biophysica Acta 1777 (2008) 1079–1091contact with His-202 in its own monomer through Tyr-16, thus
establishing a potential communication pathway between His-202 of
bothmonomers. The interaction pattern of this helix is similar in other
bc1 complexes, but with different residues occupying the correspond-
ing positions; Asp-31 in the Rhodobacter capsulatus [5] and Leu-21 in
the bovine [53] bc1 complexes interact with His-202 of the same
monomer just as Tyr-16 does in the yeast enzyme, and the role of yeast
Tyr-9 in contacting the vicinity of the opposite center N is taken by
Leu-21 in bacteria. Vertebrate bc1 structures are too disordered in the
region corresponding to Tyr-9 in yeast to identify the precise
interaction with the other monomer[1–3], although the high degree
of movement in this region could reﬂect a dynamic role of this amino-
terminal helix in relaying conformational information between
monomers [53].
4. Inter-monomeric electron equilibration between cytochrome b
subunits
4.1. Theoretical calculations involving electron equilibration between
center N sites via the bL hemes
The possibility of electron transfer between the cytochrome b
subunits in the dimer had been considered as a possible explanation
for kinetic results even before the structure of the enzymewas known
[12,54], although it was assumed that equilibration could occur
directly between the bH hemes. The ﬁrst crystal structure of the bc1
complex that became available revealed that the distance between the
bL hemes, but not between the bH hemes, was short enough to permit
electron transfer between monomers [55]. As shown in Fig. 8 for the
yeast dimer [4], the edge-to-edge distance between the bL hemes is
13.8 Å, which is not too far from the 12.4 Å that separate the bL and bH
hemes in each monomer. According to the simpliﬁed equation for the
calculation of electron transfer rates when redox centers have the
same potential [56], a distance of 13.8 Å would allow a tunneling rate
of 3.27×104 s−1. This is more than 100 times faster than the maximum
rate of quinol oxidation measured in the yeast bc1 complex, which is
~3×102 s−1 [57]. Thus, on the basis of distance considerations, electron
equilibration between monomers via the bL hemes can be expected to
occur continuously between catalytic events at center P. However, thehigher redox potential of the bH heme makes it more probable for an
electron residing in a bL heme to be transferred to center N of its own
monomer. The calculated rate of bL to bH electron tunneling for yeast
can be estimated to be ~1.3×106 s−1 based on the equation for
calculating an exergonic electron transfer [56]. Therefore, the question
arises of whether electron equilibration between center N sites
(or between center P in one monomer and center N in the other) is
relevant in comparison to the bc1 complex turnover rate.
We have presented simulations showing the time-scale at which
an electron residing in one bH heme in the dimer would equilibrate
into the opposite monomer using a range of rates for each individual
electron transfer between hemes [45]. We showed that intra-dimer
equilibration could occur within 40 ms even at the slowest rates
assumed. Others have addressed this issue using rates calculated from
electron tunneling equations [56,58] and concluded that inter-
monomeric electron transfer is expected to be relevant especially
under physiological conditions in which an electrochemical potential
across the membrane decreases the tendency of electrons to move
from bL to bH, or when the bH heme is pre-reduced by reverse electron
transfer at center N.
The simulation shown in Fig. 9 uses the simple equilibrationmodel
between the four b hemes in the dimer that we have described
previously [45], but with electron tunneling rates calculated from the
distance and redox potential parameters of the yeast enzyme.
Assuming Em values of 80 mV for bH and −50 mV for bL (ΔEm=130 mV
[56]), Fig. 9 shows that, even in the absence of a trans-membrane
potential, an electron originally residing in one bH heme should
equilibrate to the other monomer within 10 ms (solid lines). This
estimate results from using an equation for calculating the rate of the
endergonic bH to bL electron transfer that is different from the
exergonic bL to bH step [59]. If the exergonic equation is used to
calculate both tunneling events, as has recently been proposed [60],
the bH to bL transfer changes from 8.9×103 s−1 to 3.2×104 s−1. The net
result of this different approach is a faster bH to bH equilibration that
is complete within 3 ms (dotted lines in Fig. 9), roughly equivalent to
the time-scale of maximal quinol oxidation at center P in the yeast
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sharing between bH and bL resulting from the two calculations is
quite different (40.6 compared to 146.1 using the lower and higher bH
to bL transfer rates, respectively). Still, equilibration between the four
b hemes in the dimer would be completed within 10 ms in both
scenarios.
Using data obtained with the bacterial bc1 complex in chromato-
phores [61], it has been shown that the Keq for electron transfer
between the two b hemes in a monomer is much lower (10–25) than
would be predicted from the Boltzmann distribution of one electron
between two redox centers separated by 130–140 mV (Keq ~200),
implying Coulombic interactions between the hemes. This seems to be
supported experimentally by the increase of 70–80 mV in the redox
potential of the bL heme when either one of the histidines that
coordinates the bH heme is mutated, resulting in the absence of bH in
the enzyme [62]. However, it should be pointed out that, on purely
theoretical grounds, it is impossible for the equilibration of one
electron between the bH and bL hemes to be inﬂuenced by any
electrostatic (Coulombic) effect of the ferro-bH heme on the ferri-bL
heme. This is because movement of the electron from the reduced bH
heme to the oxidized bL heme would eliminate the putative source of
the Coulombic effect in the bH heme as it becomes oxidized. Therefore,
the fact that the redox potential of the bL heme is in reality only 50–
60 mV lower than that of the bH heme implies a Keq ~10 for the
distribution of a single electron between the b hemes in a monomer.
Obviously, this value would allow even faster equilibration between
the two bH hemes in the dimer than what is shown in Fig. 9, since the
electron would reside a longer period of time in the bL hemes.
Nevertheless, the simulations we show in Fig. 9 using tunneling rate
calculations indicate that, even at signiﬁcantly higher Keq values of
N100 resulting from a slower bH to bL electron transfer, fast electron
equilibration via the bL hemes in the dimer would still be expected.
4.2. Experimental evidence for fast inter-monomeric electron transfer
The crystal structure of the bc1 complex shows that the space
between the bL hemes is occupied by three aromatic residues, one of
which (Phe-195 in Rhodobacter sphaeroides) has been proposed to be
relevant for electron equilibration between monomers [63]. Mutation
of this residue to alanine increased the rate of superoxide generation
by the bc1 complex three-fold, while decreasing the catalytic activity
by ~20%. However, it was not directly shown that this mutationFig. 10. Reduction of the bH heme in antimycin-inhibited center N sites by inter-monomeric
reduction of the bH heme at a center N where antimycin (Ant) has been bound before additi
center N in the othermonomer (yellow curved arrow). The arrival of the electron to the bH he
antimycin molecule. As shown in panel B, this expected spectral shift does occur (insert) w
follows the predicted relative concentration of dimers with only one antimycin at center N
reproduced from Ref. [45].affected electron equilibration between cytochrome b subunits.
Moreover, electron tunneling is generally considered to be dependent
on distance and driving force, more than on the particular residues
located in the space separating redox groups [59]. Therefore, it is
possible that the Phe-195 mutation in the bacterial enzyme induces a
change in the overall conformation of center P, or even modiﬁes the
redox potential of the bL hemes, resulting in increased electron leak-
age to oxygen when quinol is oxidized.
We have obtained more direct evidence for intra-dimer electron
transfer by using the experimental approach shown in Fig. 10 [45].
When antimycin is added in substoichiometric concentrations, a
fraction of the bc1 complex dimers will bind the inhibitor at only one
center N. If quinol is then added to this population of dimers
(previously blocked at center P by adding a stoichiometric concentra-
tion of myxothiazol), the bH heme will undergo reduction through the
uninhibited center N and semiquinone will be formed. As shown in
Fig. 10A, the bH heme at the center N where antimycin is bound will
not undergo reduction unless it is able to equilibrate with the unin-
hibited center N in the other monomer via bL to bL electron transfer.
If the electron reaches the inhibited center N, antimycin will modify
the spectrum of its ferro-bH heme, and a corresponding red shift will
be detected.
As shown in Fig. 10B, where data from Ref. [45] is reproduced, this
is exactly what we observed, with the relative amplitude of the red
shift induced by antimycin corresponding to the calculated proportion
of dimers with only one antimycin bound at center N. This experiment
reports electron transfer between monomers if antimycin, a tightly
bound inhibitor, is assumed not to dissociate from the oxidized center
N and rebind to the quinol-reduced site in the other monomer during
the time-scale of the assay, which was b1 s. We excluded this
possibility by showing that fast dissociation rates for antimycin would
preclude the observed inhibition of bH reduction at center N at
stoichiometric concentrations [45]. We also measured the association
rate constant for antimycin binding, and from this value and the Kd we
calculated a very slow dissociation rate of ~10−5 s−1 [45].
Even considering that the effective concentration of antimycin in
the detergent micelles is higher than that calculated for the total
aqueous solution volume, this would mainly affect the value of those
parameters expressed in units of concentration, such as the Kd and the
association rate constant. The effective dissociation rate, which is
expressed only in units of time, would still be very low. A low off rate
has been experimentally demonstrated for funiculosin in the bovineelectron transfer. As shown in panel A, when both center P sites in a dimer are blocked,
on of quinol (QH2) can only take place if an electron is transferred from the uninhibited
me in the inhibitedmonomer can be detected by the spectral shift induced by the bound
ith a relative magnitude (black data points) at different antimycin/enzyme ratios that
(shown by the red curve). Experimental conditions were the same as in Fig. 2A. Data
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these inhibitors are bound to center N, they dissociate on a time-scale
of tens of minutes asmeasured by the change in spectral shift of the bH
heme upon addition of antimycin. Funiculosin and ilicicolin have Kd
values 1–3 orders of magnitude higher than antimycin, implying that
the dissociation rate constant for antimycin is even lower, at least as
low as our estimated value of 10−5 s−1. The argument that antimycin
might dissociate from center N into the lipid or detergent phase much
faster than into the aqueous volume in which Kd determinations are
made [54] is also disproved by the extremely slow exchange between
funiculosin or ilicicolin and antimycin when these are mixed together
in the bc1 phospholipid/detergent micelle [64,65], since these are all
highly hydrophobic inhibitors.
For antimycin to bind to the quinol-reduced center N site and
induce a spectral shift in the absence of inter-monomeric electron
transfer, semiquinone would need to vacate the site where it was
formed on a millisecond time-scale. This contradicts the strong
stabilization of semiquinone at center N, which behaves as a tightly
bound ligand. Therefore, the result shown in Fig. 10 is direct evidence
for fast electron equilibration between the center N sites in the dimer
by means of bL to bL electron tunneling. Additional evidence was
obtained from the non-linear inhibition of the extent of cytochrome b
reduction by antimycin [45], and as mentioned previously (see Figs. 5
and 6), from the kinetic modeling of the partial inhibition by quinone
[41].
The kinetics traces and simulations that are shown in Fig. 11 and
taken from Ref. [15] make it evident that cytochrome b reduction
through quinol oxidation at center P can be explained only if electrons
are able to rapidly equilibrate between the cytochrome b subunits in
the dimer. We have shown that, when center N sites are fully blocked
with antimycin, the extent of cytochrome b reduced by quinol can be
accurately simulated by assuming that two turnovers at one center P
reduce both bH hemes in the dimer, concomitantly with the reduction
of cytochrome c1 and the Rieske protein in the active monomer, after
which no more turnovers can occur due to the lack of acceptors in the
high potential chain of the active center P (Fig. 11A and Ref. [15]). In
contrast, the assumption that electrons remain only in the active
monomer results in a lower amount of cytochrome b reduction than is
observed, even if bL is allowed to undergo reduction (pink dashed
traces in Fig. 11B). In agreement with the modeling of cytochrome c1
reduction kinetics explained before (see Fig. 2), signiﬁcantly more
cytochrome b reduction than observed should be expected if both
center P sites are assumed to be active (blue solid traces in Fig. 11B).Fig. 11. Cytochrome b reduction kinetics in the presence of antimycin. In panel A, 1.5 μM yea
reduction traces (red traces) that were simulated closely by assuming that one center P is a
curves). Panel B shows the simulated extents of cytochrome b reduction assuming catalysis
assuming catalysis at both center P sites (solid blue curves). Data and simulations are fromOverall, these results conﬁrm the functional relevance of the close bL
to bL distance observed in the bc1 structures.
The linear decrease in the extent of bH reduction at substoichio-
metric concentrations of myxothiazol that has apparently been found
in the bacterial bc1 complex in the presence of saturating antimycin
has been used as an argument against electron transfer between
monomers [66]. The rationale of this argument, which predicts a
hyperbolic titration curve if there is electron transfer between
monomers, is incorrect. Assuming that only one of the center P sites
in the dimer is active in the presence of antimycin [15,18,28] and that
myxothiazol is able to bind with the same afﬁnity to both the active
and the inactive monomers as shown by our data [18,28], linear
titrations would also be obtained even if there exists intra-dimeric
electron transfer. This is because an uninhibited dimer with only one
active center P site would generate the same extent of bH reduction as
that produced by 50% of the dimers with one myxothiazol bound
(those with the inhibitor in the already inactive monomer). The other
50% of the dimers, those having myxothiazol at the single active site,
would generate no bH reduction, the same as in the dimers with two
myxothiazol molecules bound. When averaged over the enzyme
population, the net result of these two binding scenarios would be a
directly proportional loss of bH reduction as a function of inhibitor
concentration that would result in a linear titration curve reaching a
value of zero at a ratio of one myxothiazol per monomer. The
observation that myxothiazol does generate a non-linear inhibition of
the extent of cytochrome b (and c1) reduction in the bc1 complex from
Neurospora crassa [54], suggests that in some species the inactive
monomer can be switched onwhen the active one is inhibited, making
the effect of electron equilibration between monomers more evident.
5. Physiological signiﬁcance of the regulatory interactions within
the bc1 complex dimer
Regulation of the quinol and quinone binding sites along with
inter-monomer electron transfer in the bc1 dimer confers the
advantage of allowing maximal quinol oxidation at center P in spite
of the unavoidable reverse reactions that occur as semiquinone is
stabilized at center N [41]. We have shown by simulations [45] that if
the bc1 complex functioned as an independent monomer, direct bH
reduction concomitant to the formation of a tightly bound semiqui-
none at center N would be favored at higher quinol/quinone ratios,
resulting in an increased potential for center P inhibition and electron
leakage to oxygen.st bc1 complex reduced by the indicated quinol (QH2) equivalents yielded cytochrome b
ble to reduce both bH hemes in the dimer by inter-monomeric electron transfer (black
at one center P without inter-monomeric electron transfer (dashed magenta curves) or
Ref. [15].
Fig. 12. Inhibition of the steady-state ubiquinol–cytochrome c reductase activity of the yeast bc1 complex by antimycin. Panel A shows data points (black circles) from four separate
experiments in which the activity of 50 nM yeast bc1 complex was determined in the presence of various amounts of antimycin. The change in the activity as antimycin is added can
be explained by assuming that only onemonomer is active in the absence of inhibitor and that bothmonomers become activewhen only one center N is blocked (simulated by the red
curve). Assuming that both monomers are active in the absence of antimycin and with one inhibitor per dimer (simulated by the blue curve) does not explain the experimental data,
nor does the assumption that each monomer that binds antimycin becomes inactive (simulated by the green curve). Panel B shows the relative concentrations of free and inhibitor-
complexed monomers and dimers as a function of antimycin concentration from which the curves in panel A were obtained: free monomers (green solid line), antimycin-bound
monomers (green dashed line), unbound dimers (blue curve), dimers with one inhibitor (red solid curve) and dimers with two inhibitors (red dashed line). Data and simulations are
from Ref. [15].
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steady-state activity of the bc1 complex with substoichiometric con-
centrations of antimycin, as shown in the data of Fig. 12, taken from
Ref. [15]. As antimycin concentration increases, a fraction of center N
sites equal to the concentration of the inhibitor is blocked, preventing
electrons to leave cytochrome b. If eachmonomer functioned indepen-
dently, center P catalysis would come to a stop after at most two
turnovers once the inhibitor blocked the center N site in that particular
monomer. This would result in a linear decrease of the steady-state
activity of the enzyme as a function of antimycin concentra-
tions (green line in Fig. 12). The experimental points (solid circles)
clearly do not follow this behavior, showing instead an increase in the
catalytic activity when ~25% of the center N sites are blocked with
antimycin. It should be noted that this apparent activation cannot be
explained by alternative models that assume that the non-linear
titration curves with antimycin are due to a fast movement of the
inhibitor directly between center N sites [54], for which there is no
structural support, since the crystal structures do not show any chan-
nel that would allow direct interchange of center N ligands between
monomers [1–5,13].
Inter-monomer electron transfer by itself would allow the two
center P sites in the dimer to recycle electrons out of cytochrome b
through a single center N site, resulting in an increased resistance of
the activity to antimycin (blue curve in Fig. 12A). However, the
experimental data can only be explained by amodel inwhich only half
of the center P sites function in the absence of antimycin and if
simultaneous catalysis at both center P sites occurs upon binding of
one inhibitor per dimer (red curve in Fig. 12A). This comes from the
assumption that those dimers occupied by one antimycin (red curve in
Fig. 12B) contribute twice as much to the total activity as do the
uninhibited dimers (blue curve in Fig. 12B). Electron transfer between
the two monomers is also a condition in this mechanism, allowing
electrons from the two active center P sites to leave cytochrome b
through the uninhibited center N site. The result of this dimeric mode
of bc1 complex catalysis is that the net activity of quinol oxidation
is fully resistant to a blockage of up to 50% of the center N sites,highlighting the physiological relevance of this dimeric mechanism in
minimizing inhibition of center P by backward reactions at center N.
Considering all of the experimental observations explained in this
review, a model for the regulation of quinol oxidation in the dimeric bc1
complex can beproposed as shown in Fig.13 andpreviously discussed in
Ref. [36]. The ﬁrst key feature in thismechanism is an inverse symmetry
relation between center P and center N that allows only one Rieske
protein to approach center P when both center N sites are either vacant
(intermediate I in Fig.13), or occupied by semiquinone (intermediate III).
Conversely, both Rieske proteinswould have access to quinol at center P
when there is an asymmetry at center N inwhich semiquinone is bound
to only one monomer (intermediates II and IV).
The second key feature of this dimeric mechanism is the rapid
equilibration of electrons between the two cytochrome b subunits,
which allows semiquinone stabilization at either (intermediates II and
IV) or both center N sites (intermediate III), regardless of which center
P the electrons come from. This intra-dimer electron transfer would
favor the situation inwhich the dimer has both bH hemes oxidized and
adjacent to semiquinone (similar to intermediate III), which allows
only one center P to be active. This state of the enzyme is optimal to
avoid electron leakage to oxygen, since it presents six potential accep-
tors (two bL hemes, two bH hemes and two semiquinones) for elec-
trons coming from quinol oxidation at center P.
The state in which both center P sites are able to oxidize quinol
simultaneously (intermediates II and IV) might create the risk of too
many electrons being delivered into cytochrome b. However, bH
reduction at the vacant center N by reverse quinol oxidation (not
shown in Fig. 13) would be prevented by rendering stabilization of a
second semiquinone unfavorable as long as both Rieske proteins are in
a catalytically competent conﬁguration (see Fig. 6). Furthermore, the
high mobility of the Rieske protein domain [37] would make it
unlikely for a conformation with two Rieske proteins in the vicinity of
center P to be a stable intermediate. Even if the conﬁguration inwhich
simultaneous catalysis at center P occurs is stabilized by binding
one antimycin per dimer (see Fig. 12), electron transfer between
monomers and the fast rate of reactions at center N would allow
Fig. 13.Model of regulation of quinol oxidation in the dimeric cytochrome bc1 complex.
Cytochrome b subunits are shown as blue rectangles with potentially active center P
sites as green ovals occupied by quinol (QH2) with the Rieske protein extrinsic domain
(yellow) proximal to cytochrome b. Center N sites are indicated by orange ovals where
quinol (QH2) or quinone (Q) bind to form semiquinone (SQ). Black and gray arrows
within dimers represent possible electron transfer steps between hemes (red circles)
that result in a corresponding conversion (black or gray arrows between dimers)
between intermediates. See text and Ref. [36] for a detailed description of the model.
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in the absence of inhibitors, center N reactions would favor a fast
transition towards the conformation that has only one active center P
(intermediates I and III).
The brief intervals during which only one semiquinone is
occupying center N in a dimer (intermediates II and IV) would allow
the previously inactive center P to reach a catalytically active
conformation with the Rieske protein approaching the substrate
(intermediates II and IV). Which of the two center P sites oxidizes
quinol ﬁrst would be a matter of random chance, resulting in the two
center P sites undergoing the same number of turnovers on average.
Thus, this is an alternating site mechanism of quinol oxidation [67],
although each monomer would not necessarily become inactive after
a ﬁxed number of turnovers to allow activity in the second site. This is
emphasized in Fig. 13 by the black and gray arrows, which represent
equally probable electron pathways and ligand binding or dissociation
events that would result in conversions between dimer conforma-
tions. Whether a particular dimer intermediate follows a conversion
pathway indicated by a black or by a gray arrow would depend on the
particular redox state of each bH heme at the time of a quinol
oxidation event, which would favor the electron ending up in the
same monomer or in the opposite one by bL to bL mediated transfer.
This proposed mechanism of stochastically-alternating center P
sites controlled by semiquinone stabilization at center N would confer
signiﬁcant ﬂexibility to the bc1 complex dimer. Its main advantage
would be to allow quinol oxidation to proceed unhindered by reverse
center N reactions, resulting in enhanced resilience to different
quinol/quinone ratios and trans-membrane potentials generated by
the variable energetic conditions of the respiratory chain. Only in the
presence of very high (and possibly non-physiological) electrochemi-
cal gradients would center P slow down and start to leak electrons to
oxygen due to the tendency of electrons to stay in the bL hemes. The
highly damaging reactions that would ensue if the bc1 complex did
not have regulatory mechanisms to minimize oxygen radical forma-
tion constitute a strong selective pressure that explains the strict
conservation of the dimeric structure of this enzyme throughout the
evolution of aerobic organisms.Acknowledgement
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